News

Cantech Letter3d
Vertex Announces Marketing Authorization in Canada for ALYFTREK, a Once-Daily Next-Generation CFTR Modulator for the Treatment of Cystic Fibrosis
In head-to-head clinical trials, ALYFTREK was non-inferior on ppFEV1 and superior in reducing sweat chloride compared to ...
Applied Clinical Trials Online11d
Walgreens’ Clinical Trials Journey: Three Years In
In this video interview, Ramita Tandon, chief biopharma officer at Walgreens, reflects on the company’s three-year evolution ...